Interactive session on Contemporary Ayurveda: Difference between revisions

Eganeesh (talk | contribs)
Agnivesha (talk | contribs)
No edit summary
Line 38: Line 38:
}}
}}


This article is based on interactive session with Padma Shree Prof.R.H.Singh on July 11, 2021.
This article is based on interactive session with Padma Shree Prof.R.H.Singh on July 11, 2021.The video session can be accessed on the link of facebook page.
<div style="text-align:justify;">
<div style="text-align:justify;">
An online interactive session was organized by [[Charak Samhita Research, Training and Skill Development Centre]] (CSRTSDC), I.T.R.A, Jamnagar. Padma Shree Prof.R.H.Singh, lifetime Distinguished Professor from Banaras Hindu University, Varanasi guided in the session on current important issues of [[Ayurveda]] and healthcare field. Dr.Gopal Basisht, senior rheumatologist and project director, Charak Samhita New Edition Project, Orlando, USA presided over the session. Prof.S.K.Sharma Khandel, Director, ArogyaLaxmi, Jaipur and Prof.G.S.Tomar, President, Vishva [[Ayurveda]] Mission, Prayagraj actively participated in the session. The session was moderated by Dr.Yogesh Deole, Project Co-ordinator, Charak Samhita New Edition Project. Prof.R.H.Singh guided on following issues.
An online interactive session was organized by [[Charak Samhita Research, Training and Skill Development Centre]] (CSRTSDC), I.T.R.A, Jamnagar. Padma Shree Prof.R.H.Singh, lifetime Distinguished Professor from Banaras Hindu University, Varanasi guided in the session on current important issues of [[Ayurveda]] and healthcare field. Dr.Gopal Basisht, senior rheumatologist and project director, Charak Samhita New Edition Project, Orlando, USA presided over the session. Prof.S.K.Sharma Khandel, Director, ArogyaLaxmi, Jaipur and Prof.G.S.Tomar, President, Vishva [[Ayurveda]] Mission, Prayagraj actively participated in the session. The session was moderated by Dr.Yogesh Deole, Project Co-ordinator, Charak Samhita New Edition Project. Prof.R.H.Singh guided on following issues.